Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Short-term Investments (2016 - 2026)

Pharma-Bio Serv's Short-term Investments history spans 12 years, with the latest figure at $4.8 million for Q1 2026.

  • For Q1 2026, Short-term Investments fell 6.45% year-over-year to $4.8 million; the TTM value through Jan 2026 reached $4.8 million, down 6.45%, while the annual FY2025 figure was $7.5 million, 25.05% up from the prior year.
  • Short-term Investments reached $4.8 million in Q1 2026 per PBSV's latest filing, down from $7.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $11.7 million in Q3 2023 to a low of $4.5 million in Q4 2023.
  • Average Short-term Investments over 4 years is $7.2 million, with a median of $6.8 million recorded in 2025.
  • Peak YoY movement for Short-term Investments: skyrocketed 80.98% in 2024, then crashed 45.89% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $4.5 million in 2023, then skyrocketed by 31.93% to $6.0 million in 2024, then grew by 25.05% to $7.5 million in 2025, then crashed by 35.84% to $4.8 million in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Short-term Investments are $4.8 million (Q1 2026), $7.5 million (Q4 2025), and $6.8 million (Q3 2025).